All Articles

As People Incorporated's CFO preps for a key tech conference, the real story isn't about magazines. It's about a radical bet on experiences, data, and Vegas.

A major partnership aims to educate millions on new medications. But can virtual group chats truly close the deadly gap between prescription and understanding?

Zillow's Q2 revenue soars 18%, but a deeper look reveals a complex reality: declining user traffic, a GAAP net loss, and a high-stakes antitrust battle.

DOOR (formerly Latch) cuts a third of its staff, citing AI efficiency. The move highlights a harsh new reality in proptech, balancing innovation with survival.

With a fresh $10M, Worldscape is arming government agencies with AI agents and digital worlds. This is the story of their rapid rise and why it matters.

GRAIL’s Galleri test shows stunning clinical results and sales growth, but staggering financial losses and a looming FDA review create a high-wire act for innovation.

A stunning 159% profit surge for Empire Life in Q2. Favorable interest rates and popular new products tell one story, but their tech spending tells another.

A new partnership in Churchill's iconic tourism sector sees Gambler First Nation move from the sidelines to the boardroom, aiming to redefine Arctic tourism.

As record heat stresses backyard pools, a new playbook emerges. We dissect how climate change is forcing an industry to adapt and what it means for homeowners.

Revolve Renewable Power bets big on Ontario's battery market with a new acquisition, but its high-interest, related-party financing raises critical questions.

The building products giant wraps its 109-year legacy in the flag for America's 250th, but a closer look reveals a calculated play on innovation and sustainability.

ASUS unveils its full-stack AI hardware, betting that the future of enterprise AI lies in powerful, secure, on-premise systems you can control.

A new Salmonella outbreak sparks the first lawsuit against Chipotle, reigniting concerns over its food safety promises and its vulnerable supply chain.

MovingPlace's new API isn't just a product launch; it's a tectonic shift, replacing frustrating lead-gen models with a seamless, integrated future.

A new 'cognitive density' metric from LingEQ finds a pre-AI paper by Claude Shannon is more profound than Turing's work. It's a bold claim with a bigger target: the broken system of scientific publishing.

With three major industry accolades, Cellhub is solidifying its role as a key aggregator, simplifying complex 5G/6G deployments for channel partners.

Phoenix Nest secures a pivotal $3M NIH grant to manufacture a potential cure for Sanfilippo syndrome, a fatal childhood disease with no current treatment.

The new Gordie Howe Bridge is more than steel and asphalt; its multi-use path creates the first international link for the Trans Canada Trail, sparking a new era of active tourism.

A South Korean pet health firm's U.S. sales surged 850%. Now, armed with breakthrough AIM science, Greycoat Research is making its biggest move yet.

Dr. Andrew Bridge joins AndHealth, revealing a deeper strategy to tackle chronic conditions by blending top-tier expertise with a disruptive, access-focused model.